Proposed code: BOD
Issue price: $0.20
Principal acitivies: Development of innovative biomedical devices
Corporate: Michael Bennett (CEO); Robert Towner (executive director); Robert Scott (non-executive director); and Caroline Bentley (company secretary).
bioMD plans to raise $5 million from a 20 cent a share offer scheduled to close on March 31.
Sponsoring broker: Bell Potter Securities Limited
© Business News 2018. You may share content using the tools provided but do not copy and redistribute.